Etoricoxib
Generic Name
Etoricoxib 60 mg Tablet
Manufacturer
Multiple manufacturers globally
Country
Global
Loading images...
Price Details
Current market pricing information
Variant | Unit Price | Strip Price |
---|---|---|
etoricoxib 60 mg tablet | ৳ 6.00 | ৳ 60.00 |
Description
Overview of the medicine
Etoricoxib is a selective cyclooxygenase-2 (COX-2) inhibitor belonging to the class of NSAIDs, used for the symptomatic relief of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and for the treatment of acute pain and primary dysmenorrhea.
Uses & Indications
Dosage
Adults
Osteoarthritis: 30 mg or 60 mg once daily. Rheumatoid arthritis/Ankylosing spondylitis: 90 mg once daily. Acute gouty arthritis: 120 mg once daily for maximum 8 days. Acute pain/Primary dysmenorrhea: 60 mg or 90 mg once daily for maximum 8 days. The 60 mg is common for acute pain and osteoarthritis.
Elderly
No dose adjustment generally required, but caution is advised in elderly patients due to increased risk of side effects.
Renal_impairment
Mild to moderate renal impairment: No dose adjustment. Severe renal impairment (creatinine clearance <30 mL/min): Not recommended.
How to Take
Orally, with or without food. Taking with food may slightly delay absorption, but it does not affect the extent of absorption.
Mechanism of Action
Etoricoxib selectively inhibits cyclooxygenase-2 (COX-2), an enzyme responsible for the synthesis of prostaglandins, which are mediators of pain and inflammation. By inhibiting COX-2, it reduces pain and inflammation while potentially sparing COX-1 mediated protective effects in the gastrointestinal tract.
Pharmacokinetics
Onset
Within 24 minutes for acute pain, peak effect within 1-2 hours.
Excretion
Mainly via urine (70%) and feces (20%) as metabolites, very little unchanged drug is excreted.
Half life
Approximately 22 hours.
Absorption
Rapidly absorbed after oral administration, peak plasma concentrations reached in approximately 1 hour.
Metabolism
Extensively metabolized in the liver, primarily by cytochrome P450 enzymes (CYP3A4) to inactive metabolites.
Side Effects
Contraindications
- Hypersensitivity to etoricoxib or any component of the tablet
- Active peptic ulceration or gastrointestinal bleeding
- Severe hepatic dysfunction
- Severe renal dysfunction (creatinine clearance <30 mL/min)
- Inflammatory bowel disease
- Congestive heart failure (NYHA II-IV)
- Established ischemic heart disease, peripheral arterial disease, and/or cerebrovascular disease
- Uncontrolled hypertension
- Pregnancy and lactation
Drug Interactions
Lithium
Increased plasma levels of lithium, leading to toxicity.
Rifampicin
Decreased plasma levels of etoricoxib.
Methotrexate
Increased plasma levels of methotrexate, leading to toxicity.
Oral contraceptives
Increased plasma concentrations of ethinyl estradiol.
Cyclosporine, Tacrolimus
Increased nephrotoxicity.
Warfarin and other anticoagulants
Increased risk of bleeding.
ACE inhibitors / Angiotensin II antagonists / Diuretics
Reduced antihypertensive effect, increased risk of renal impairment.
Storage
Store below 30°C in a dry place, away from direct light and moisture. Keep out of reach of children.
Overdose
In case of overdose, symptomatic and supportive treatment should be initiated. There is no specific antidote. Dialysis is unlikely to be effective in removing etoricoxib.
Pregnancy & Lactation
Contraindicated during pregnancy and lactation. NSAIDs, including etoricoxib, should be avoided in the third trimester of pregnancy due to the risk of premature closure of the ductus arteriosus and fetal renal dysfunction. A decision must be made whether to discontinue nursing or to discontinue the drug.
Frequently Asked Questions
Common questions about this medicine
Pack Sizes
Shelf Life
Usually 2-3 years from manufacturing date.
Availability
Pharmacies, hospitals, clinics
Approval Status
Approved by major regulatory bodies (e.g., EMA, FDA in some regions, DGDA)
Patent Status
Expired in most regions; generic versions available
Clinical Trials
Extensive clinical trials have demonstrated efficacy and safety for approved indications. Ongoing post-marketing surveillance and studies continue to evaluate long-term cardiovascular safety.
Lab Monitoring
- Blood pressure monitoring (especially in hypertensive patients)
- Liver function tests (periodically during long-term treatment)
- Kidney function tests (creatinine, BUN, periodically)
- Complete blood count (periodically, especially with long-term use)
Doctor Notes
- Always consider the patient's cardiovascular risk profile before prescribing etoricoxib.
- Use the lowest effective dose for the shortest duration necessary, especially in patients with risk factors for cardiovascular disease.
- Monitor blood pressure regularly during treatment.
- Avoid use in patients with significant renal or hepatic impairment.
Patient Guidelines
- Take the lowest effective dose for the shortest duration necessary.
- Report any signs of gastrointestinal bleeding (black, tarry stools) or cardiovascular issues (chest pain, shortness of breath) immediately.
- Do not exceed the recommended dose.
- Inform your doctor about all other medications you are taking, including over-the-counter drugs and herbal supplements.
Missed Dose Advice
If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and resume your regular dosing schedule. Do not take a double dose to make up for a missed one.
Driving Precautions
May cause dizziness, vertigo, or somnolence. Patients should be cautious when driving or operating machinery until they know how etoricoxib affects them.
Lifestyle Advice
- Maintain a healthy diet and regular exercise, especially for osteoarthritis.
- Avoid smoking and excessive alcohol consumption to reduce cardiovascular and gastrointestinal risks.
- Manage underlying conditions like hypertension and diabetes effectively.
Alternative Medicines in Bangladesh
Similar medicines available in the market
Global Brand Names
International brand names for this medicine
Related
Medicines
Explore similar medicines to find the best option for your healthcare needs.
Axovit
Reputable Pharma Ltd.
Lotenate Plus
General Pharmaceuticals Ltd.
Azilpres
Specific manufacturer varies by region (e.g., Square Pharmaceuticals Ltd. in BD for a generic Azilsartan product)
Exalin
Square Pharmaceuticals Ltd.
Timozin
MediCorp Pharma Ltd.
Exipain
Acme Laboratories Ltd.
EveFlex
MediCore Pharmaceuticals Ltd.
Evoloxin
Incepta Pharmaceuticals Ltd.
Exomi MUPS
Square Pharmaceuticals Ltd.
Exler
Incepta Pharmaceuticals